Delayed sample arrival at the laboratory does not lead to more false negatives in the Danish population screening for colorectal cancer.

about

Delayed sample arrival at the laboratory does not lead to more false negatives in the Danish population screening for colorectal cancer.

Item

http://www.wikidata.org/entity/Q47949172

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Delayed sample arrival at the ...... reening for colorectal cancer.

@en

Delayed sample arrival at the ...... reening for colorectal cancer.

@nl

type

Item

label

Delayed sample arrival at the ...... reening for colorectal cancer.

@en

Delayed sample arrival at the ...... reening for colorectal cancer.

@nl

prefLabel

Delayed sample arrival at the ...... reening for colorectal cancer.

@en

Delayed sample arrival at the ...... reening for colorectal cancer.

@nl

P1476

Delayed sample arrival at the ...... reening for colorectal cancer.

@en

P2093

Anette Tarp Hansen

http://www.w3.org/2001/XMLSchema#string

Betina Klint Nielsen

http://www.w3.org/2001/XMLSchema#string

Birgitte Reinholdt

http://www.w3.org/2001/XMLSchema#string

Elke Hoffmann-Lücke

http://www.w3.org/2001/XMLSchema#string

Karin Heidemann

http://www.w3.org/2001/XMLSchema#string

Nete Hornung

http://www.w3.org/2001/XMLSchema#string

Peter Hindersson

http://www.w3.org/2001/XMLSchema#string

P2860

A quantitative immunochemical fecal occult blood test for colorectal neoplasia

Cochrane systematic review of colorectal cancer screening using the fecal occult blood test (hemoccult): an update.

False negative fecal occult blood tests due to delayed sample return in colorectal cancer screening.

Immunochemical faecal occult blood test: number of samples and positivity cutoff. What is the best strategy for colorectal cancer screening?

Cutoff value determines the performance of a semi-quantitative immunochemical faecal occult blood test in a colorectal cancer screening programme.

Colorectal cancer screening: a global overview of existing programmes.

Global patterns and trends in colorectal cancer incidence and mortality.

Sensitivity, but not specificity, of a quantitative immunochemical fecal occult blood test for neoplasia is slightly increased by the use of low-dose aspirin, NSAIDs, and anticoagulants.

Impact on colorectal cancer mortality of screening programmes based on the faecal immunochemical test.

Influence of sample return time and ambient temperature on the performance of an immunochemical faecal occult blood test with a new buffer for colorectal cancer screening.

P304

685-688

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/00365513.2017.1379091

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-09-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28933963

http://www.w3.org/2001/XMLSchema#string

P921

colorectal cancer